<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03747588</url>
  </required_header>
  <id_info>
    <org_study_id>Pumch06342</org_study_id>
    <nct_id>NCT03747588</nct_id>
  </id_info>
  <brief_title>The Comparision of Laparoscopic and Open Pancreaticoduodenectomy for Pancreatic Cancer</brief_title>
  <acronym>LOPA</acronym>
  <official_title>The Effect and Safety of Comparision Between Laparoscopic and Open Pancreaticoduodenectomy for Pancreatic Cancer : A Randomized Prospective Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Minimally invasive pancreaticoduodenectomy remains one of the most challenging abdominal
      procedures. Safety and feasibility remain controversial when comparing laparoscopic with open
      pancreaticoduodenectomy,especially for malignant tumors.The aim of this study was to compare
      laparoscopic and open pancreatoduodenectomy for short-term outcomes in a randomized trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is to compare the efficiency and safety between laparoscopic and open
      pancreaticoduodenectomy for pancreatic cancer. We design a prospective randomized study.
      Patients with malignant pancreatic tumor who underwent pancreatoduodenectomy are recruited to
      the study. After obtaining informed consent, eligible patients are randomly allocated to
      laparoscopic or open group before the operation day . The outcomes evaluated were hospital
      stay, and blood loss, radicality of surgery, duration of operation and complication rate.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall complications</measure>
    <time_frame>Up to postoperative 30 days</time_frame>
    <description>The proportion of all complications after operation accounted for the total number of patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pancreatic fistula</measure>
    <time_frame>Up to postoperative 30 days</time_frame>
    <description>The international study group (ISGPF) definition: A drain output of any measurable volume of fluid on or after postoperative day 3 with an amylase content greater than 3 times the serum amylase activity. Three different grades of postoperative fistula (grades A, B, C) are defined according to the clinical impact on the patient's hospital course.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intra-abdominal bleeding</measure>
    <time_frame>Up to postoperative 30 days</time_frame>
    <description>The International Study Group of Pancreatic Surgery (ISGPS) definition: Blood loss through abdominal drains or nasogastric tube;hematemesis or melena; clinical deterioration of the patient; unexplained hypotension or tachycardia; or laboratory findings such as a decreasing hemoglobin concentration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intra-abdominal infection</measure>
    <time_frame>Up to postoperative 30 days</time_frame>
    <description>Positive cultures of collection of fluid or blood,or persistent fever necessitating treatment with antibiotics and positive detection in image test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay (day)</measure>
    <time_frame>Up to postoperative 2 weeks</time_frame>
    <description>Participants will be followed for the duration of hospital stay, an expected average of 2 weeks</description>
  </secondary_outcome>
  <other_outcome>
    <measure>progression-free survival</measure>
    <time_frame>Up to postoperative 5 years</time_frame>
    <description>The period between the beginning of treatment and the observation of disease progression or the occurrence of death for any reason.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pancreatic Carcinoma</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Laparoscopic Pancreaticoduodenectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LPD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open Pancreaticoduodenectomy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>OPD</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laparoscopic pancreaticoduodenectomy</intervention_name>
    <description>Laparoscopic resection of pancreatic tumor</description>
    <arm_group_label>Laparoscopic Pancreaticoduodenectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Open pancreaticoduodenectomy</intervention_name>
    <description>open resection of pancreatic tumor</description>
    <arm_group_label>Open Pancreaticoduodenectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: &gt;18yr, &lt;75yr

          -  Patients with pancreatic cancer or non-pancreatic cancers (biliary duct cancer or
             ampullary cancer) who underwent pancreatoduodenectomy

          -  Preoperative imaging assessment is resectable or borderline resectable

        Exclusion Criteria:

          -  Benign tumors of the head of pancreas

          -  Enhanced CT diagnosis revealed that the excess of SMV was more than 180 degrees, or
             distant metastasis.

          -  conversion to laparotomy because of intraoperative difficulty
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Menghua Dai, MD</last_name>
    <phone>+861069152600</phone>
    <email>DaiMH@pumch.cn</email>
  </overall_contact>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 16, 2018</study_first_submitted>
  <study_first_submitted_qc>November 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2018</study_first_posted>
  <last_update_submitted>November 20, 2018</last_update_submitted>
  <last_update_submitted_qc>November 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>laparoscopic pancreaticoduodenectomy</keyword>
  <keyword>open pancreaticoduodenectomy</keyword>
  <keyword>pancreatic cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

